학술논문

A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)
Document Type
Article
Source
In: Vaccine. (Vaccine, 16 May 2023, 41(21):3387-3398)
Subject
Language
English
ISSN
18732518
0264410X